1. A Substituted Anilino Enaminone Acts as a Novel Positive Allosteric Modulator of GABAAReceptors in the Mouse Brain
- Author
-
Wang, Ze-Jun, Sun, Liqin, Jackson, Patrice L., Scott, Kenneth R., and Heinbockel, Thomas
- Abstract
A small library of anilino enaminones was analyzed for potential anticonvulsant agents. We examined the effects of three anilino enaminones on neuronal activity of output neurons, mitral cells (MC), in an olfactory bulb brain slice preparation using whole-cell patch-clamp recording. These compounds are known to be effective in attenuating pentylenetetrazol-induced convulsions. Among the three compounds tested, 5-methyl-3-(4-trifluoromethoxy-phenylamino)-cyclohex-2-enone (KRS-5Me-4-OCF3) showed potent inhibition of MC activity with an EC50of 24.5 μM. It hyperpolarized the membrane potential of MCs accompanied by suppression of spontaneous firing. Neither ionotropic glutamate receptor blockers nor a GABABreceptor blocker prevented the KRS-5Me-4-OCF3-evoked inhibitory effects. In the presence of GABAAreceptor antagonists, KRS-5Me-4-OCF3completely failed to evoke inhibition of MC spiking activity, suggesting that KRS-5Me-4-OCF3-induced inhibition may be mediated by direct action on GABAAreceptors or indirect action through the elevation of tissue GABA levels. Neither vigabatrin (a selective GABA-T inhibitor) nor 1,2,5,6-tetrahydro-1-[2-[[(diphenylmethylene)amino]oxy]ethyl]-3-pyridinecarboxylic acid hydrochloride (NNC-711) (a selective inhibitor of GABA uptake by GABA transporter 1) eliminated the effect of KRS-5ME-4-OCF3on neuronal excitability, indicating that the inhibitory effect of the enaminone resulted from direct activation of GABAAreceptors. The concentration-response curves for GABA are left-shifted by KRS-5Me-4-OCF3, demonstrating that KRS-5Me-4-OCF3enhanced GABA affinity and acted as a positive allosteric modulator of GABAAreceptors. The effect of KRS-5Me-4-OCF3was blocked by applying a benzodiazepine site antagonist, suggesting that KRS-5Me-4-OCF3binds at the classic benzodiazepine site to exert its pharmacological action. The results suggest clinical use of enaminones as anticonvulsants in seizures and as a potential anxiolytic in mental disorders.
- Published
- 2011
- Full Text
- View/download PDF